PAYDEN & RYGEL INVESTMENT GROUP

PAYDEN & RYGEL INVESTMENT GROUP is the U.S. registered investment company complex associated with Payden & Rygel, an independent institutional asset manager headquartered in Los Angeles, California. Payden & Rygel was founded in 1983 by Joan A. Payden and has built a long-standing franchise in active fixed income, global multi-asset, and complementary equity strategies for institutional and intermediary clients. PAYDEN & RYGEL INVESTMENT GROUP serves as the fund platform for a range of U.S.-domiciled mutual funds and related vehicles advised by Payden & Rygel. The Investment Group files with the U.S. Securities and Exchange Commission as an institutional investment manager under CIK #0000885709. Its Form 13F filings aggregate the reportable long U.S. equity and ADR positions held across the Payden-branded mutual funds and any other pooled vehicles within the complex that are required to report. Given the firm’s heritage in fixed income, a substantial portion of underlying strategies are bond-focused and therefore not visible in Form 13F. The equity and equity-linked holdings disclosed each quarter nonetheless provide a consistent, regulator-defined view into how the complex implements its listed-equity sleeves, particularly within balanced, global equity, and income-oriented products. When organized as a multi-year 13F History, these filings can be used to observe the evolution of the Investment Group’s U.S. equity footprint over time.

At the complex level, PAYDEN & RYGEL INVESTMENT GROUP offers a lineup of mutual funds spanning core and specialty fixed income, global and U.S. equities, and multi-asset strategies. The adviser’s core competency lies in active fixed income and global macro, but the platform also includes equity and balanced funds designed to provide complementary sources of capital growth and income. The 13F-reportable positions arise primarily from these equity and multi-asset mandates. In the U.S. equity sleeve, Payden & Rygel applies a fundamentally driven, research-intensive process. Portfolios are benchmark-aware but not index-hugging, seeking to own companies with durable business models, solid balance sheets, and predictable cash flows at valuations that are reasonable relative to long-term earnings and dividend prospects. Style-wise, the approach at the fund-complex level can be characterized as core-plus and income-oriented: the funds tend to blend quality growth franchises with more value- and dividend-focused holdings, often tilted toward large- and mid-cap issuers. Sector allocations in the 13F record are typically diversified across financials, healthcare, information technology, consumer discretionary and staples, industrials, and selectively other areas. Equity exposure is often integrated within balanced and multi-asset strategies that combine stocks with substantial allocations to high-quality bonds and cash managed by the same platform. As a result, the equity holdings disclosed by PAYDEN & RYGEL INVESTMENT GROUP should be interpreted as the equity component of a wider fixed income–anchored architecture. For allocators, the firm’s filings offer granular insight into the complex’s 13F Portfolio Composition over time—issuer counts, sector and capitalization mix, and the degree to which the U.S. equity sleeve tilts toward dividend payers, defensives, or more cyclical growth sectors as macro conditions and valuation signals evolve.

Viewed through its filings under CIK #0000885709, PAYDEN & RYGEL INVESTMENT GROUP appears as the mutual fund and pooled-vehicle platform of an established fixed income–centric asset manager, with equity exposures playing a complementary role within multi-asset and income-oriented mandates. The 13F record shows diversified, long-only U.S. equity holdings—largely in high-quality large- and mid-cap names across core sectors—implemented with moderate turnover and integrated into a broader fixed income framework rather than run as standalone aggressive equity bets. For allocators using 13F data as a secondary lens, organizing the Investment Group’s disclosures into a consistent 13F History and analyzing them via a Portfolio Simulator or related Backtesting Service allows for a detailed examination of implementation behavior: how sector and style tilts in the equity sleeve have shifted across cycles, how concentrated the largest positions have been, and how reconstructed equity-only capital trajectories have compared with broad benchmarks. Performance Backtests Online based on these holdings—anchored in 13F Portfolio Composition, equity Volatility Profile, reconstructed Historical Track Record, and implied Sharpe Ratio—provide a quantitative cross-check on how the equity components of Payden & Rygel–advised funds have interacted with different macro and market regimes. Because the 13F lens omits the fixed income engines at the heart of many PAYDEN & RYGEL INVESTMENT GROUP strategies, it should be combined with full fund documentation, including prospectuses and fixed income risk reports, to form a complete view. As interest-rate dynamics, credit conditions, and equity style leadership continue to evolve, a key open question for allocators is how sensitive the complex’s equity sleeves will be to future shifts in equity and rate regimes, and how those sensitivities interact with its core fixed income exposures in a diversified, multi-manager portfolio.

The overall risk profile of PAYDEN & RYGEL INVESTMENT GROUP is shaped primarily by its fixed income and multi-asset heritage: many funds in the complex are bond or balanced mandates where interest-rate, credit, and duration exposures are central risk drivers. The 13F disclosures, however, isolate only the long U.S. equity and ADR positions, and thus reflect the risk characteristics of the listed-equity sleeves embedded within broader strategies. Within this equity subset, key risk dimensions include: - Broad equity beta, as the funds’ stock allocations are materially exposed to U.S. and global equity-market moves - Style factors such as large- versus mid-cap, and tilts toward quality, dividend payers, and moderately valued growth franchises - Sector allocation across financials, healthcare, technology, consumer, industrials, and other core sectors Because the U.S. equity sleeve is constructed within the context of income and multi-asset objectives, it tends to emphasize established, liquid issuers and diversified sector exposure rather than highly concentrated thematic bets. Single-name risk is moderated by multi-name portfolios, but not eliminated—top holdings and recurring issuer exposures can still drive a meaningful share of capital fluctuations. In broad equity drawdowns, the reconstructed equity sleeve would be expected to experience material declines, with resilience or vulnerability shaped by the prevailing balance between cyclicals and defensives. Using historical 13F data, allocators can estimate an indicative Volatility Profile for the reportable equity holdings by mapping each security to its price history and replaying the aggregated portfolios through time. When these reconstructed holdings are run in a Portfolio Simulator or Backtesting Service—normalized to a user-defined starting notional—they yield a proxy Historical Track Record for the U.S. equity sleeve: the trajectory of capital through different equity and rate regimes, the depth and duration of drawdowns, and the pace of recoveries. From that path, one can derive risk-adjusted diagnostics such as an implied Sharpe Ratio, alongside measures of downside capture and sector-level contributions to risk. These analytics apply strictly to the 13F-reportable equity portion of the Investment Group’s activities. They do not incorporate the dominant fixed income exposures, cash management, or any use of derivatives within individual funds, all of which are central to the complex’s overall risk and capital-behavior profile.